Reckitt Benckiser Group

Reckitt Benckiser Group

World Rank (Jul-30-2023)
310
Market Cap (Jul-30-2023)
55.03 Billion USD
World Rank (Dec-25-2022)
300
Market Cap (Dec-25-2022)
50.35 Billion USD
World Rank (Jan-07-2022)
293
Market Cap (Jan-07-2022)
62.30 Billion USD
World Rank (Jan-01-2021)
242
Market Cap (Jan-01-2021)
63.48 Billion USD
Company Rank in Country in 2023
Company rank in UK in July-2023 is 12
Company Rank in Country in 2022
Rank in UK in 2022 is 13
World Region
Europe
World Subregion
Northern Europe
CEO
Laxman Narasimhan
Chairman
Christopher A. Sinclair
Founders
Isaac Reckitt
Jeremiah Colman
Johann Benckiser
Billionaires
Matthias Reimann Andersen
Renate Reimann Haas
Stefan Reimann Andersen
Wolfgang Reimann
Employee Count
40,000
Employee Count as of Date
As on 2023
Headquarters Country
UK
Headquarters City/State
Slough
Annual Revenue in USD
18,564 Million USD
Annual Operating Income in USD
4,155 Million USD
Annual Net Income in USD
2,993 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
36,918 Million USD
Total Liabilities in USD
24,738 Million USD
Total Equity in USD
12,181 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector LC
FMCG
HealthCare Products
Consumer Non Durables
Consumer Goods
Company Website
RECKITT BENCKISER GROUP PLC
Wikipedia
Wikipedia
Yahoo
Yahoo @ OTC
Company Profile

Reckitt Benckiser Group is Consumer Goods and FMCG Products manufacturing Company related to health brands, cleanliness brands, hygiene brands and personal care products.

They have more than 40 thousand employees working across 6 continents in 60 different locations as on 2023. Headquarters is in UK.

Company products are used by generations of families that have grown up with Reckitt products. RECKITT BENCKISER GROUP unrivalled range provides health, hygiene and nutrition for people in 200 countries around the world. 

RECKITT BENCKISER GROUP PRODUCTS:

  • AIRWICK.
  • CALGON.
  • CLEARASIL.
  • CILLIT BANG.
  • DETTOL.
  • DUREX.
  • ENFA.
  • FINISH.
  • GAVISCON.
  • HARPIC.
  • LYSOL.
  • MUCINEX.
  • MORTEIN.
  • NUROFEN.
  • STREPSILS.
  • VANISH.
  • VEET.
  • WOOLITE.
  • AIRBORNE.
  • MOVEFREE.
Facts About Company

Reckitt Benckiser Group annual revenue was 14,453 Million GBP and annual net income was 2,330 Million GBP for year ending Dec-2022.

Reckitt Benckiser Group annual revenue generated for period ending Dec-2021 was 13,234 million GBP.

Reckitt Benckiser Group annual net income generated for period ending Dec-2021 was -32 million GBP.

Reckitt Benckiser Group had 40,000 employees as on 2023.

Annual Results Summary LC

RECKITT BENCKISER GROUP - Annual Results - Revenue and Net Profit - in Million GBP:

Year - EndingRevenueOperating IncomeNet Income
Dec-202214,4533,2352,330
Dec-202113,2342,714-32 (Loss)
Dec-202013,9933,1451,187
Dec-201912,8463,286-3,683 (Loss)
Dec-201812,5973,2802,161
Dec-201711,5122,9636,172
Balance Sheet Summary LC

RECKITT BENCKISER GROUP - Balance Sheet Summary - in Million GBP:

RECKITT BENCKISER GROUP Total Assets as on June-2022 was 69,097 Million GBP.

RECKITT BENCKISER GROUP Total Liabilities as on June-2022 was 31,408 Million GBP.

RECKITT BENCKISER GROUP Total Equity as on June-2022 was 37,689 Million GBP.

Quarterly Results Summary LC

RECKITT BENCKISER GROUP - Quarterly Results Summary - in Million GBP

Quarterly Ending:Total RevenueNet Income
Jun-20237,4501,230
Mar-20237,570991
Dec-20226,8901,350
Sep-20226,6401,690
Founded Year
1823
ISIN Code
GB00B24CGK77
Stock Category LC
FTSE 100
S&P EUROPE 350
Stock Exchange LC
LSE